Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease

Julie Gonneaud, Christophe Bedetti, Alexa Pichet Binette, Tammie L.S. Benzinger, John C. Morris, Randall J. Bateman, Judes Poirier, John C.S. Breitner, Sylvia Villeneuve

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Objective: To determine whether years of education and the ϵ4 risk allele at APOE influence β-amyloid (Aβ) pathology similarly in asymptomatic individuals with a family history of sporadic Alzheimer disease (AD) and presymptomatic autosomal dominant AD mutation carriers. Methods:We analyzed cross-sectional data from 106 asymptomatic individuals with a parental history of sporadic AD (PREVENT-AD cohort; age 67.28 ± 4.72 years) and 117 presymptomatic autosomal dominant AD mutation carriers (DIAN cohort; age 35.04 ± 9.43 years). All participants underwent structural MRI and Aβ-PET imaging. In each cohort we investigated the influence of years of education, APOE ϵ4 status, and their interaction on Aβ-PET. Results:Asymptomatic individuals with a parental history of sporadic AD showed increased Aβ burden associated with APOE ϵ4 carriage and lower level of education, but no interaction between these. Presymptomatic mutation carriers of autosomal dominant AD showed no relation between APOE ϵ4 and Aβ burden, but increasing level of education was associated with reduced Aβ burden. The association between educational attainment and Aβ burden was similar in the 2 cohorts. Conclusions:While the APOE ϵ4 allele confers increased tendency toward Aβ accumulation in sporadic AD only, protective environmental factors, like increased education, may promote brain resistance against Aβ pathology in both sporadic and autosomal dominant AD.

Original languageEnglish (US)
Pages (from-to)E1554-E1564
JournalNeurology
Volume95
Issue number11
DOIs
StatePublished - Sep 15 2020

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease'. Together they form a unique fingerprint.

Cite this